Antigens recognized on human tumors by cytolytic T lymphocytes: towards vaccination?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 7549898.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
It has been known for many years that cytolytic T lymphocytes that specifically recognize the tumor cells of the same patient can be derived from the blood of melanoma patients. Several of the antigens recognized by these antitumor T lymphocytes have now been completely identified. Some of them are sufficiently tumor-specific to envision their use as antitumor vaccines in selected cancer patients.
Medical subject headings
- Antigens, Neoplasm
- Neoplasms
- T-Lymphocytes, Cytotoxic
- Vaccination